Ondansetron 8mgTablet
Gastrointestinal

Ondansetron 8mg

Ondansetron Hydrochloride

Selective 5-HT3 receptor antagonist antiemetic for chemotherapy-induced and post-operative nausea and vomiting. Manufactured by Cipla and Sun Pharma for oncology and hospital export.

Strengths

4mg / 8mg

Packing

10 tablets/strip

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Request QuotationWhatsApp
Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Ondansetron Hydrochloride 4mg / 8mg
Dosage Form
Tablet
Available Strengths
4mg / 8mg
Packing
10 tablets/strip
Route of Administration
Oral or intravenous
Dosage
CINV: 8mg 30 minutes before chemo, then 8mg every 12 hours for 1-2 days; PONV: 4mg IV at induction
Indications
Chemotherapy-induced nausea and vomiting, post-operative nausea and vomiting, radiation-induced nausea
Country of Origin
India (WHO-GMP Certified)
Storage
Store below 30°C, protect from light
Shelf Life
36 months
Side Effects
Headache, constipation, diarrhea, dizziness, fatigue, QTc prolongation
Precautions
QTc prolongation at high IV doses; avoid in congenital long QT syndrome; dose adjustment in hepatic impairment; serotonin syndrome risk with SSRIs

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Omeprazole 20mgCapsule

Omeprazole 20mg

Omeprazole

Proton pump inhibitor that irreversibly inhibits the gastric H+/K+-ATPase enzyme, achieving over 90% acid suppression and revolutionizing the treatment of acid-peptic diseases since its launch. The world's most prescribed PPI and a WHO Essential Medicine, with India being a major global supplier of affordable omeprazole capsule and injectable formulations.

10mg / 20mg / 40mg
Esomeprazole 40mgTablet

Esomeprazole 40mg

Esomeprazole Magnesium

S-enantiomer of omeprazole with reduced first-pass metabolism delivering higher and more consistent plasma levels than racemic omeprazole, resulting in superior acid suppression for erosive esophagitis healing. The enteric-coated tablet formulation enables convenient once-daily dosing with consistently better gastric acid control across CYP2C19 genetic polymorphism groups.

20mg / 40mg
Rabeprazole 20mgTablet

Rabeprazole 20mg

Rabeprazole Sodium

Non-enzymatic, non-CYP2C19-dependent PPI that undergoes predominantly non-enzymatic metabolism, providing more predictable and consistent acid suppression across all patient genetic phenotypes compared to other PPIs. Preferred in patients on clopidogrel (reduced drug interaction risk) and in CYP2C19 poor/ultra-rapid metabolizers.

10mg / 20mg

Need bulk pricing for Ondansetron 8mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote